
ASND, GDS, ADSK and CDZI among after hours movers
15.34BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04351P1012
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-3.11
Dividend Share
-
Dividend Yield
-
Earnings Share
-4.25
Wall Street Target Price
295.23
EPS Estimate Current Year
4.42
EPS Estimate Next Year
10.31
EPS Estimate Current Quarter
-0.245
EPS Estimate Next Quarter
0.4278
Most Recent Quarter
-
Revenue TTM
720,131,968
Gross Profit TTM
625,217,024
EBITDA
-131,415,000
Profit Margin
-31.67%
Return On Assets TTM
-6.86%
Return On Equity TTM
-818.43%
Revenue Per Share TTM
11.882
Qtly Revenue Growth YOY
42.30%
Diluted Eps TTM
-4.25
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
46
Price Sales TTM
20.6064
Price Book MRQ
78.1335
Enterprise Value Revenue
17
Enterprise Value EBITDA
-20
894.76
25.66%849.47
2.55%443.92
1.90%154.93
1.89%305.59
1.32%323.87
0.93%750.14
0.56%24.79
0.49%310.04
-3.11%97.43
-2.88%